EX-FILING FEES 4 d831302dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Axogen, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

               
Security Type  

Security
Class

Title

  Fee
Calculation
Rule
  Amount
Registered(1)
 

Proposed
Maximum

Offering
Price Per
Unit(3)

 

Maximum
Aggregate
Offering

Price

 

Fee

Rate

 

Amount of

Registration
Fee

               
Equity   Common Stock, $0.01 par value per share   Other(3)   2,500,000(2)   $7.60   $19,000,000   .00014760   $2,804.40
               
Equity   Common Stock, $0.01 par value per share   Other(3)   1,050,000(4)   $7.60   $7,980,000   .00014760   $1,177.85
         
Total Offering Amounts     $26,980,000     $3,982.25
         
Total Fee Offsets         — 
         
Net Fee Due               $3,982.25

 

(1)

Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock, $0.01 par value (the “Common Stock”) of Axogen, Inc. (the “Registrant”), which become issuable under the Axogen, Inc. Third Amended and Restated 2019 Long-Term Incentive Plan (the “Second Amended 2019 Plan”) by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of Common Stock.

(2)

Represents an additional 2,500,000 shares of Common Stock of the Registrant issuable under the Third Amended 2019 Plan.

(3)

Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act, based on the average of the high and low sales prices of the Common Stock as reported on The Nasdaq Capital Market on August 5, 2024, which was $7.60 per share.

(4)

Represents 1,050,000 shares of Common Stock of the Registrant issuable upon the settlement of performance stock units granted to Michael Dale on August 9, 2024, outside of the Axogen, Inc. Amended and Restated 2017 Employee Stock Purchase Plan and the Axogen, Inc. Inducement Equity Incentive Plan as an inducement material to entry into employment with the Registrant, in accordance with Nasdaq Listing Rule 5635(c)(4).